Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000489008 | SCV000576491 | uncertain significance | not provided | 2017-05-02 | criteria provided, single submitter | clinical testing | The T900M variant in the DCHS1 gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The T900M variant is observed in 9/65120 (0.014%) alleles from individuals of European background, in the ExAC dataset (Lek et al., 2016). The T900M variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved in mammals. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. We interpret T900M as a variant of uncertain significance. |
Labcorp Genetics |
RCV000489008 | SCV002381719 | likely benign | not provided | 2024-10-29 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003333072 | SCV004040651 | uncertain significance | Van Maldergem syndrome 1 | 2023-02-06 | criteria provided, single submitter | clinical testing |